Study of Milnacipran in Patients With Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Public ClinicalTrials.gov record NCT01077375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability and Efficacy of Milnacipran in Patients With an Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
Study identification
- NCT ID
- NCT01077375
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Forest Laboratories
- Industry
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Milnacipran Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2010
- Primary completion
- Nov 30, 2010
- Completion
- Dec 31, 2010
- Last update posted
- Jan 25, 2012
2010 – 2011
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 013 | Sacramento | California | 95825 | — |
| Forest Investigative Site 022 | Cromwell | Connecticut | 06416 | — |
| Forest Investigative Site 021 | Danbury | Connecticut | 06810 | — |
| Forest Investigative Site 007 | Delray Beach | Florida | 33484 | — |
| Forest Investigative Site 008 | Ocala | Florida | 34471 | — |
| Forest Investigative Site 009 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 016 | Orlando | Florida | 32806 | — |
| Forest Investigative Site 012 | St. Petersburg | Florida | 33709 | — |
| Forest Investigative Site 019 | Tampa | Florida | 33614 | — |
| Forest Investigative Site 006 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 024 | Atlanta | Georgia | 30328 | — |
| Forest Investigative Site 015 | Evansville | Indiana | 47713 | — |
| Forest Investigative Site 005 | Worchester | Massachusetts | 01610 | — |
| Forest Investigative Site 010 | Jackson | Mississippi | 39202 | — |
| Forest Investigative Site 025 | St Louis | Missouri | 63141 | — |
| Forest Investigative Site 018 | Willingboro | New Jersey | 08046 | — |
| Forest Investigative Site 014 | Syracuse | New York | 13210 | — |
| Forest Investigative Site 023 | Charlotte | North Carolina | 28209 | — |
| Forest Investigative Site 002 | Cincinnati | Ohio | 45219 | — |
| Forest Investigative Site 003 | Cleveland | Ohio | 44122 | — |
| Forest Investigative Site 001 | Medford | Oregon | 97504 | — |
| Forest Investigative Site 020 | Mechanicsburg | Pennsylvania | 17055 | — |
| Forest Investigative Site 011 | Greer | South Carolina | 29651 | — |
| Forest Investigative Site 004 | Salt Lake City | Utah | 84102 | — |
| Forest Investigative Site 017 | Bellevue | Washington | 98007 | — |
| Forest Investigative Site 026 | Racine | Wisconsin | 53406 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01077375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 25, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01077375 live on ClinicalTrials.gov.